Trial NCT03615924

View at ClinicalTrials.gov 
Org. Study IDs: D5136C00009

Last trial update was posted on 2021-04-09

MeSH Interventions

Ticagrelor

MeSH Conditions

Anemia, Sickle Cell

Other Conditions

Sickle Cell Disease

Stopping Reasons

Recommendation from an independent data monitoring committee (DMC) and accepted by AstraZeneca.

Limitations And Caveats

AstraZeneca took the decision to terminate the study early, following a recommendation from the independent Data Monitoring Committee. This early termination was not considered to have had an impact on the robustness of the study results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID